Optimal methods for analyzing targeted pairwise knockout screens

Juihsuan Chou1,2, Nazanin Esmaeili Anvar1, Reem Elghaish1,2

  • 1Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Abstract

Insights

Synthetic lethality, a cancer treatment strategy, can be improved by accounting for gene paralogs. The Z-transformed delta log fold change (ZdLFC) method consistently identifies synthetic lethal interactions from CRISPR screens across cell lines.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Synthetic lethality targets cancer-specific genetic vulnerabilities for selective tumor cell death.
  • Single-gene knockout screens may miss synthetic lethal interactions due to functional redundancy from paralog genes.
  • Multiplex CRISPR systems (Cas9, Cas12a) are used for genetic interaction assays, but method comparisons are lacking.

Purpose of the Study:

  • To systematically compare bioinformatic approaches for identifying synthetic lethality from CRISPR screens.
  • To evaluate the performance of different scoring methods in the context of paralogous genes.
  • To identify a robust method for analyzing multiplex CRISPR screening data.

Main Methods:

  • Utilized data from four in4mer CRISPR/Cas12a screens in cancer cell lines.
  • Applied three bioinformatic approaches: delta log fold change (dLFC), Z-transformed dLFC (ZdLFC), and rescaled dLFC (RdLFC).
  • Assessed the consistency of synthetic lethal pair identification across different cell lines for each method.

Main Results:

  • Both ZdLFC and RdLFC demonstrated more consistent identification of synthetic lethal pairs compared to the unscaled dLFC method.
  • The ZdLFC method provided reproducible results across multiple cancer cell lines.
  • No training set of known positive interactors was required for ZdLFC or RdLFC.

Conclusions:

  • The ZdLFC method provides a robust framework for scoring synthetic lethal interactions from CRISPR screens involving paralogous genes.
  • This method enhances the reliability of synthetic lethality discovery by ensuring consistent results across diverse cell lines.
  • ZdLFC offers a valuable tool for cancer research without the need for pre-existing interaction data.